From todays announcement regarding SubB2M cancer-specific probe.
"BARD1 had a post-Sienna acquisition cash position of approximately $10.4 million at 31 July 2020 that will be used to fund its ongoing research, development and commercial programs"
Wild
From todays announcement regarding SubB2M cancer-specific...
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
50.0¢ |
Change
-0.025(4.76%) |
Mkt cap ! $55.76M | |||
| Open | High | Low | Value | Volume |
| 53.0¢ | 53.0¢ | 50.0¢ | $160.3K | 315.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 40373 | 49.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 52.0¢ | 9050 | 1 |
View Market Depth
| Last trade - 15.58pm 13/09/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |